CUPRIC SULFATE - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for cupric sulfate and what is the scope of patent protection?
Cupric sulfate
is the generic ingredient in three branded drugs marketed by Abraxis Pharm and Am Regent, and is included in three NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.Summary for CUPRIC SULFATE
| US Patents: | 1 |
| Tradenames: | 3 |
| Applicants: | 2 |
| NDAs: | 3 |
| Raw Ingredient (Bulk) Api Vendors: | 119 |
| Patent Applications: | 13 |
| DailyMed Link: | CUPRIC SULFATE at DailyMed |
US Patents and Regulatory Information for CUPRIC SULFATE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Am Regent | TRALEMENT | cupric sulfate; manganese sulfate; selenious acid; zinc sulfate | SOLUTION;INTRAVENOUS | 209376-002 | Dec 2, 2020 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Abraxis Pharm | CUPRIC SULFATE | cupric sulfate | INJECTABLE;INJECTION | 019350-001 | May 5, 1987 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Am Regent | TRALEMENT | cupric sulfate; manganese sulfate; selenious acid; zinc sulfate | SOLUTION;INTRAVENOUS | 209376-002 | Dec 2, 2020 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
| Am Regent | TRALEMENT | cupric sulfate; manganese sulfate; selenious acid; zinc sulfate | SOLUTION;INTRAVENOUS | 209376-001 | Jul 2, 2020 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
